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Abstract 
 
Objective: There is continuing debate about long-term effects of brain injury. We examined a 
range of TBI variables (TBI history, severity, frequency, and age of injury) as predictors of 
cognitive outcome over 8 years in an adult population, and interactions with APOE genotype, 
sex and age-cohort.  
Methods: Three randomly sampled age cohorts (20-24, 40-44, 60-64 years at baseline; N= 
6333) were each evaluated three times over eight years. TBI variables, based on self-report, 
were separately modelled as predictors of cognitive performance using linear mixed effects 
models.   
Results: TBI predicted longitudinal cognitive decline in all three age groups. APOE 4+ 
genotypes in the young and middle-aged groups predicted lower baseline cognitive 
performance in the context of TBI. Baseline cognitive performance was better for young 
females than males but this pattern reversed in middle age and old age.  
Conclusions: The findings suggest TBI history is associated with long-term cognitive 
impairment and decline across the adult lifespan. A role for APOE genotype was apparent in 
the younger cohorts but there was no evidence that it is associated with impairment in early 
old age. The effect of sex and TBI on cognition varied with age-cohort, consistent with a 
proposed neuroprotective role for oestrogen.  
 
Keywords: cognitive decline, epidemiology, head injury, dementia, prospective study 
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The role of traumatic brain injury (TBI) in long-term cognitive impairment and decline 
remains controversial. Although studies have reported that a history of TBI is a risk factor for 
late-life cognitive impairment and neurodegenerative disease, including Alzheimer’s 
dementia (Lye & Shores, 2000; Plassman et al., 2000; Wang et al., 2012), it is clear that other 
factors modify this relationship, including injury severity (Rohling et al., 2011) frequency (D. 
H. Smith, Johnson, & Stewart, 2013), age (Teasdale, Nicoll, Murray, & Fiddes, 1997), as 
well as genetics (Friedman, Froom, & Sazbon, 1999) and sex (Stein, 2001).  
Because these factors influence mechanisms of recovery from TBI and susceptibility to later 
neuropathology (see Dardiotis, Grigoriadis, & Hadjigeorgiou, 2012; Lye & Shores, 2000), it 
is important to understand their role in long-term cognitive outcomes post-TBI. A major 
difficulty in comparing findings across studies is the variety of head-injury variables 
examined, study duration, sensitivity of outcome measures and other key factors reported. 
Furthermore, very few studies have focused on multiple factors of interest such as genotype 
and sex within the one sample to understand their relative contribution to TBI outcome (Ost 
et al., 2008; Ponsford et al., 2011), or TBI in relation to neurodevelopment and change across 
the lifespan (Teasdale, Murray, & Nicoll, 2005). Findings from these studies suggest the 
relationship between TBI outcome and factors such as genotype, may vary with sex and age. 
The present study uses a large, prospective dataset to examine three factors of current 
interest: APOE genotype, sex and age, in relation to neuropsychological outcome after TBI. 
In addition, a range of TBI variables were examined in the one sample, including severity, 
frequency and age of first injury, with the objective of understanding how these TBI variables 
interact with the above factors to explain cognitive outcome across the lifespan. 
 
Despite increasing knowledge of the molecular processes in brain injury, clinical and 
epidemiological evidence has been far from unanimous in supporting patterns of associations 
predicted by molecular studies. The biological response to TBI is highly variable across 
individuals and injury mechanisms. In general, neurotrauma initiates a complex cascade of 
molecular processes within the brain some of which exacerbate neuronal death and others 
which are neuroprotective. These processes include neuroinflammation, oxidative stress, 
excitoxicity, apoptotic cell death, neurodegeneration, and plasticity. Of the several genes 
identified as influencing this molecular response to injury, the gene for apolipoprotein E is 
the most studied and pertinent to the question of late-life neurodegeneration after TBI 
(Dardiotis et al., 2012; Kokjohn, Maarouf, & Roher, 2011; Liu, Kanekiyo, Xu, & Bu, 2013). 
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Compared to TBI patients who carry only the 2 and 3 isoforms of the APOE gene, carriers 
of the 4 isoform are more likely to die post-injury (Teasdale et al., 1997), have a longer 
length of coma (Sorbi et al., 1995), greater neurological deficits (Friedman et al., 1999), as 
well as poorer functional outcome several years following rehabilitation (Ponsford et al., 
2011). The mechanisms underpinning the effect of APOE genotype are not well understood, 
but may influence the degree of A plaque deposition within the brain (Johnson, Stewart, & 
Smith, 2010). Acute effects of TBI such as widespread axonal injury, leads to the rapid 
accumulation of amyloid precursor proteins (APP) within the damaged axons (Gentleman, 
Nash, Sweeting, Graham, & Roberts, 1993) along with a co-accumulation of compounds that 
promote A formation. This process can persist chronically (Chen, Johnson, Uryu, 
Trojanowski, & Smith, 2009). While some studies suggest that APP plays a protective role 
post-TBI (Thornton, Vink, Blumbergs, & VanDen Heuvel, 2006), individuals with APOE 4+ 
genotype experience increased post-injury A deposition and reduced A clearance (Hartman 
et al., 2002), which may in turn lead to an increased risk of A plaque formation 
characteristic of dementia pathology. Compared to APOE 3, the APOE 4 isoform of the 
apolipoprotein E is also less able to repair synapses and protect neurons in the event of injury 
(Zhong, Scearce-Levie, Ramaswamy, & Weisgraber, 2008),  thus hindering recovery in TBI 
patients with APOE 4+ genotype.     
 
Some epidemiological studies support this link between APOE genotype and TBI outcome 
and suggest the combination of TBI history and APOE 4+genotypes significantly elevates 
the risk of long-term cognitive decline or Alzheimer’s disease, beyond the effect of either 
TBI or APOE 4+genotype alone (Katzman et al., 1996; Rohling et al., 2011; Sundstrom et 
al., 2007; Tang et al., 1996). The majority of these studies have included participants carrying 
the 2 allele within the reference group despite evidence that 2 may protect against 
degenerative neuropathology (Liu et al., 2013). Evidence for the influence of APOE genotype 
on TBI outcome is not unanimous, however, as others report cognitive decline decades after 
severe TBI but with no relationship to APOE 4+genotype (Millar, Nicoll, Thornhill, Murray, 
& Teasdale, 2003), and similarly no relationship with cognitive decline within the first two 
years following mild-moderate TBI (Chamelian, Reis, & Feinstein, 2004; Rapoport et al., 
2008). While there are numerous methodological differences across all studies, it is notable 
that the latter works used only mild/moderate TBI cases (Chamelian et al., 2004; Rapoport et 
al., 2008) or a mixed-age sample with no information on the distribution of ages (Millar et al., 
2003). TBI severity is a known factor influencing cognitive outcome and decline (Plassman 
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et al., 2000; Polusny et al., 2011), and recently age has also been found to influence TBI 
outcome.  
 
Age may influence the brain’s response to injury (e.g., Adelson et al., 2001) and also the role 
of APOE 4+ in the recovery process (Blackman, Worley, & Strittmatter, 2007). Some have 
suggested that the effect of the 4 allele on brain biology and function may be beneficial in 
the young but deleterious at older ages (Han & Bondi, 2008). Although evidence for this type 
of association in healthy individuals’ cognitive performance is mixed (Bunce, Anstey, Burns, 
Christensen, & Easteal, 2011; Ihle, Bunce, & Matthias, 2012), a number of studies that have 
used young adult samples (aged in their 20s and 30s) report improved global outcome 
(Willemse-van Son, Ribbers, Hop, van Duijn, & Stam, 2007) or faster recovery from TBI on 
neuropsychological measures of attention, executive function and episodic memory (Han et 
al., 2007). These studies however, had no older cohort against which the differential 
influence of APOE could be compared, and both used samples that were all or mostly male. 
Other works have reported the reverse pattern of findings (Teasdale et al., 2005) where the 
APOE 4+genotype was associated with poorer global outcome 6 months post injury in young 
patients. This difference decreased with increasing age, such that genotype was unrelated to 
outcome in the older patients. 
 
Sex may also moderate the relationship between TBI and long-term cognitive outcome in 
adulthood. There is evidence that circulating estrogen and progesterone have neuroprotective 
roles in mouse models of brain damage (Ardelt et al., 2012; Stein, 2001). For example, 
female rats show less brain damage than male rats and ovariectomised female rats and 
senescent rats show the same degree of brain damage as male rats (see Roof and Hall, 2000). 
Estrogen and progesterone are thought to minimize secondary injury post-TBI by reducing 
oxidative stress and neuronal death, as well as reducing cerebral oedema and enhancing 
synaptogenesis (Stein, 2001). Consistent with such findings, two meta-analyses of case-
control studies have found a stronger association between past TBI and Alzheimer’s disease 
diagnosis in males than in females (Fleminger, Oliver, Lovestone, Rabe-Hesketh, & Giora, 
2003; Mortimer et al., 1991). However, a meta-analysis of functional outcomes post-injury 
found poorer return-to-work and somatic-symptoms outcomes in females (Farace & Alves, 
2000), and other studies have failed to find any effect of sex on TBI outcome (Renner et al., 
2012). Some findings suggest that sex may also interact with genotype in predicting outcome 
of TBI. For example Ponsford et al. (2011) reported that negative outcomes in APOE 4+ 
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patients were more apparent in females than males, and particularly in patients aged over 55 
years. The authors surmised that older females may experience less neuroprotection from 
estrogen and be more vulnerable to the effects of APOE 4+. Others have reported that the 
negative effect of APOE 4+ on outcome following severe TBI is more apparent in males 
than females (albeit in a sample with mixed ages from 8 to 81 years) (Ost et al., 2008).  
 
The complex interactions that appear to influence TBI outcome are difficult to examine in 
small samples with limited age cohorts and duration of follow-up. Here, we use a large 
prospectively studied sample to investigate several self-reported TBI variables (severity, age 
of injury, and frequency) and their interaction with sex and APOE genotype as predictors of 
cognitive performance. Additionally, we implement a lifespan approach by separately 
studying these interactions in young, middle-aged and older adults.  
 
Method 
Study population 
The study population was from the Personality and Total Health (PATH) Project. The sample 
for the PATH project has previously been described in detail (Anstey et al., 2011) and has 
been shown to be representative of the 2001 Australian Census data for the area (Anstey et 
al., 2011). In brief, we surveyed three cohorts aged 20-24, 40-44 and 60-64 years at baseline 
with four yearly follow-up. The sampling frames were derived from the electoral roll in 
Canberra and Queanbeyan, Australia. Electoral registration and voting are compulsory for 
Australian citizens. Figure 1 displays the full PATH sample (N=7485) and the samples 
excluded from analysis (N=220) (see exclusion criteria below). At Wave 1, 2077 of the 
selected participants in the 20s cohort had data for both TBI and APO 4+ genotype, 2124 
participants in the 40s cohort had both TBI and APOE genotype data, and 2132 participants 
in the 60s cohort had both TBI and APOE genotype data.  
 
 
[Figure 1 here] 
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Exclusion/inclusion criteria 
To examine the association between head injury and cognitive change, participants with any 
history of cerebrovascular events (including ‘mini-strokes’ and TIAs) or epilepsy at baseline 
were excluded from the analysis. The 60s cohort included a small number of participants with 
dementia and mild cognitive disorders as classified by a previously described clinical 
assessment (Anstey et al., 2011) including comprehensive cognitive and neuropsychiatric 
evaluation. Thus, data from a total of 6333 participants were available for analysis at Wave 1. 
Sample attrition at each wave was due to death, loss to follow up, and refusal to respond to 
study-related questions, and represented on average 6.5% and 16% at wave 1 and 2 
respectively. 
 
Measures 
Head-injury variables 
Participant responses to TBI questions were combined across the three waves of data 
collection to form the following variables: (1) history of head injury, (2) number of head 
injuries sustained, (3) severity of head injury, and (4) age of first head injury (see Table 1). 
Data on the cause of TBI was also collected, but not analysed in the present study due to 
small samples, but is nevertheless presented in a descriptive format in Table 2. The variable 
‘Severity of TBI’ consisted of two levels – mild TBI and moderate/severe TBI. Mild TBI 
represented those who reported having a serious head injury but who reported a loss of 
consciousness (LOC) of less than 60 minutes or a period of memory loss (post-traumatic 
amnesia (PTA)) up to 1 day. Moderate to severe TBI was defined as cases who reported a 
loss of consciousness of 60 minutes or more and PTA of more than 1 day (Table 1). LOC has 
been used as an index of TBI severity in other epidemiological studies, and although the more 
commonly accepted cut-off for LOC in mild TBI is <30 minutes, this time interval was 
unavailable in the PATH dataset to enable this categorization. Thus the more stringent cut-off 
was used here. As indicated in Table 1, the TBI frequency data was collected only for those 
injuries with a LOC>15 minutes, and therefore does not include milder TBIs.   
 
[Table 1 here] 
 
Cognitive measures 
Cognitive testing relevant to the present paper included the following tests of episodic 
memory (delayed recall after the first trial of the California Verbal Learning Test (CVLT) 
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(Baddeley, Emslie, & Nimmo-Smith, 1993)), verbal ability/vocabulary (Spot-the-Word test 
(STW) (Delis, Kramer, Kaplan, & Ober, 1987)),  processing speed (Symbol-Digit Modalities 
test (A. Smith, 1982)), working memory (Digit-Span backwards (Wechsler, 1955)),  and 
simple reaction time.  
APOE genotyping 
DNA was extracted from buccal swabs using QIAGEN DNA Blood kits (#51162; QIAGEN, 
Hilden, Germany). Two single-nucleotide polymorphisms (SNPs; rs429358 and rs7412) were 
genotyped to identify APOE genotypes comprised of the APOE- 2, - 3 and – 4 alleles 
using TaqMan assays (Life Technologies, Carlsbad, CA) as previously described (Jorm et al., 
2007). All genotypes containing the 4 allele were combined as the composite APOE 4+ 
(4/4; 4/3; 4/2) genotype. Because of the potential protective effects of APOE 2 allele, 
we excluded individuals with 3/2 and 2/2 from the reference group. Thus APOE 4+ was 
compared against APOE 3/3.  
Procedure 
Participants were assessed individually either at their home or at The Australian National 
University. A trained interviewer administered all neuropsychological tests. Participants used 
a palmtop computer to answer the survey questions, with assistance from the interviewer if 
required. The study was approved by the Australian National University Research Ethics 
Committee, the protocol was completed in accordance with the Helsinki Declaration, and all 
participants provided written consent.  
 
Statistical Analyses 
Four head injury variables were investigated as predictors of cognitive performance. Separate 
linear mixed-effects models were created for each head injury variable, in which sex, APOE 
genotype, age cohort, time in study, and their interactions were modelled as predictors (fixed 
effects) of cognitive performance. Raw scores on the cognitive tests were standardized 
relative to each age cohort and converted to T-scores (Mean=50, SD=10). For all cognitive 
tests, including reaction time measures, higher T-scores represent better performance. Each 
model was adjusted for participants’ level of education and baseline BMI. Intercept and time 
in study were modelled as random effects. Specifically, we were interested in significant 
interactions between head injury and time, indicating that groups defined according to their 
head injury status showed different rates of cognitive change. The results of these analyses 
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are reported under longitudinal analyses (Table 3). We also examined interactions between 
head injury and APOE 4 genotype, and head injury and sex which are reported under 
Baseline Effects in Table 3.  
 
Results 
Cohort sample characteristics 
The three age cohorts varied significantly in baseline demographic characteristics including 
sex, body mass index and years of education (see Table 2). APOE genotype frequencies did 
not vary with age group (p=0.10) and were consistent with Hardy-Weinberg equilibrium 
predictions within each sample (p>0.05 for all) and with other previously published 
estimates. TBI characteristics differed across the three age cohorts. The youngest age cohort 
had a higher frequency of self-reported serious head-injuries, more childhood injuries, and 
more reports of multiple head-injuries than did the older age cohorts. The middle aged cohort 
reported a higher frequency of moderate/severe head-injury relative to the other cohorts. The 
cohorts also differed in the cause of TBI, with more traffic related TBIs in middle aged and 
more sports related TBI in the young cohort.  
 
[Table 2 here] 
 
 
Results of Linear Mixed-Effects Models 
Baseline effects involving APOE 4 
Interactions between APOE genotype and TBI in predicting baseline cognitive performance 
was evident only in the 20s and 40s cohort. There were no effects relating to APOE genotype 
in the 60s cohort (Table 3). In the 20s cohort, history of head injury predicted lower baseline 
episodic memory performance in APOE 4 carriers compared to non-carriers (i.e. APOE 3 
homozygotes) with APOE 4 carriers scoring on average 5.40 (SEM=1.79) T-score points 
lower than non-carriers (p<0.05; Figure 2A). In the 20s cohort, moderate/severe head injury 
in APOE 4 carriers was also associated with poorer memory (see Figure 2B, Table 3), and 
similarly APOE 4 carriers reporting childhood TBI also had poorer memory (Figure 2C). 
However, APOE 4 carriers reporting first TBI as an adult showed better verbal ability than 
did non-carriers (Figure 2D). APOE 4 genotype in the context of multiple TBI predicted 
poor episodic memory in the 20s cohort (Figure 2E). In the 40s cohort, APOE 4 carriers who 
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sustained their first TBI as a child had slower response times than did non-carriers reporting 
childhood TBI (B=5.92, (SEM=2.15), p<0.01) (Figure 2E). 
  
[Figure 2 here] 
 
Baseline effects involving sex 
Interactions between gender and TBI in predicting baseline cognitive performance was 
apparent in all three age groups, although the pattern of association differed across cohorts. In 
the 20s cohort, males with TBI in adulthood demonstrated poorer verbal ability relative to 
females (Figure 3A). Males with a single TBI also had poorer verbal ability relative to 
females (Figure 3B). In the 40s cohort, childhood TBI was associated with poorer memory in 
females relative to males, and females reporting a single TBI had reduced processing speed 
compared to males (Figure 3D) (B=4.86, (SEM=1.92), p<0.05). A similar pattern was 
apparent in the 60s cohort. Here, female participants reporting moderate/severe TBI had 
reduced memory performance relative to their male counterparts (B=8.75, (SEM=4.58), 
p<0.05). Females reporting mild TBI also had slower reaction times compared to males 
(B=4.88, (SEM=2.50), p<0.05).    
[Figure 3 here] 
Longitudinal effects 
 
TBI history predicted longitudinal decline in episodic memory (by -0.39 (SEM=0.13) T-score 
points per year (p<0.01; see Table 3) in the 20s cohort, and also in the 40s cohort (by -0.27 
(SEM=0.13), p<0.01). Individuals aged in their 60s who reported a history of TBI showed 
longitudinal decline in speed of processing, where performance slowed by 0.26 (SEM=0.10) 
T-scores per year (p<0.05) (Table 3). In this cohort, a similar rate of decline in processing 
speed was associated with reporting a single TBI relative to no TBI. Multiple TBI was 
associated with decline in memory for the 20s cohort, while single TBI predicted decline in 
memory in the 40s cohort. In the 20s cohort, both the childhood TBI and adulthood TBI were 
associated with decline in memory scores over time (Table 3). Adulthood TBI was also 
associated with longitudinal reduction in memory scores for the 40s cohort, whereas this 
variable was associated with decline in processing speed for the 60s cohort. 
 
[Table 3 here] 
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Discussion 
Four head injury variables were investigated as predictors of longitudinal cognitive change 
and baseline cognitive performance within three age cohorts. In addition to finding TBI-
related cognitive decline in young as well as older adults, the results indicated that sex and 
APOE genotype interacted with TBI to predict baseline differences in cognitive performance 
in a number of cognitive domains. However, these interactions varied across age-groups.  
 
Role of APOE genotype 
The cognitive performance of adults in their 20s and 40s was significantly predicted by the 
interaction between TBI and APOE genotype. We found that APOE 4 carriers in their 20s 
with a history of TBI had poorer baseline episodic memory performance compared to non-
carriers. TBI severity also interacted with genotype in this age group, such that participants 
with moderate to severe injury and the APOE 4+ genotypes had poorer episodic memory 
relative to non-carriers with moderate/severe injuries. One possibility is that the detrimental 
influence of genotype on memory in the 20s cohort may have been driven by severity of 
injury, and would not be apparent in the absence of those with moderate/severe TBI. In the 
middle-aged cohort, APOE genotype predicted slower reaction time in the context of 
childhood TBI. These findings contrast with reports that young APOE 4 carriers have better 
global or cognitive outcomes after TBI than non-carriers (Han et al., 2007; Willemse-van Son 
et al., 2007), and also broader studies indicating that APOE 4+ genotypes confer cognitive 
benefits in cognitively normal young adults (Mondadori et al., 2007). The only finding that 
may support the pattern of results in these previous works is that APOE 4 carriers reporting 
adulthood TBI in the 20s cohort demonstrated better verbal ability than did non-carriers.  
 
Another possible explanation for the discrepancy between ours and previous findings is that 
our results reflect longer-term cognitive outcomes associated with retrospective TBI history, 
whereas prior studies focused on relatively shorter-term outcomes (1 month to 3 years post 
TBI). Young participants in our study who reported adulthood TBI would have been only a 
few years post-TBI. Our findings are instead consistent with that of Teasdale et al (2005) who 
reported a negative impact of APOE 4 genotype on TBI outcome in young patients – an 
effect which became negligible with advancing age. We recently examined APOE genotype 
as a predictor of cognitive performance in healthy participants of the PATH dataset and failed 
to find evidence of a beneficial effect of APOE 4+genotype in the young cohort (Bunce et 
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al., In Press). The present work extends this to show that such a relationship is not evident in 
this dataset even in the context of TBI. 
 
The fact that we found no association between baseline cognition, TBI and APOE genotype 
for adults in their 60s contrasts with several studies (Plassman et al., 2000; Rohling et al., 
2011; Sundstrom et al., 2007). However it is consistent with others that have failed to find a 
relationship between genotype and long-term cognitive outcome in older adults (Rapoport et 
al., 2008; Teasdale et al., 2005). It is also possible that any associations between APOE 
genotype and cognitive outcome in older adults may have been masked by an interaction with 
sex as was reported by Ponsford et al (2011) in their study. We did not examine interactions 
between genotype and sex in our study. 
 
Role of sex 
Our findings suggest that the interaction between sex and TBI in predicting cognitive 
outcome varies across the lifespan. Specifically, we found that compared to females, males in 
their 20s with a single head injury or TBI as an adult had poorer verbal. In contrast, the effect 
of sex was largely reversed in both the older cohorts, with females showing lower baseline 
cognitive performance following TBI. Middle-aged females with multiple TBIs had poorer 
episodic memory than did males, and females a single TBIs had slower processing speed 
relative to males. Similarly, in the 60s females reporting either a mild or moderate TBIs had 
slower reaction times and memory respectively than did males in these categories. Although 
we did not directly examine participant levels of oestrogen and progesterone in this study or 
control for hormone replacement therapy, the pattern of associations between sex, age and 
cognitive correlates of TBI is consistent with age-related changes in the level of female 
hormones. A similar pattern was observed by Ponsford et al (2011) where global outcome 
two years post-TBI was poorer in females than in males over the age of 55 years. Oestrogen 
is thought to act as a potent antioxidant in the context of injury, while progesterone may act 
to reduce neuronal hyperexcitability post-injury (Roof & Hall, 2000). Furthermore, oestrogen 
therapy has been found to improve outcomes following cerebral ischemia and TBI in 
experimental models (Roof & Hall, 2000; Stein, 2001). Previous reports also  indicate greater 
history of TBI amongst males with Alzheimer’s disease, but not in females (Fleminger et al., 
2003; Mortimer et al., 1991). While our study suggests that cognitive outcomes are poorer for 
older females with TBI history, it is not clear whether this will trigger or exacerbate 
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pathological decline and dementia. Further follow-up of this sample will provide insight into 
the relationship between sex, TBI and dementia.  
 
TBI and cognitive decline  
Our data show that 8-year cognitive decline was significantly predicted by self-reported TBI. 
In the 20s and 40s cohorts, TBI predicted significant decline in episodic memory but this was 
not apparent in the older cohort. It is possible that effects on episodic memory reduce over 
time, but this result may also reflect a greater difficulty in recalling events in the older cohort.  
Further, the oldest cohort had the lowest baseline scores in episodic memory, and this may 
have made detection of subsequent decline more difficult. In older adults, however, we found 
that TBI predicted long-term cognitive decline primarily in speed of processing (Millar et al., 
2003; Sundstrom et al., 2007). We did not find TBI variables to predict progressive decline in 
episodic memory in this age group, which contrasts with some previous studies (Rohling et 
al., 2011). Together with the findings for APOE genotype, our data for the older adults 
suggest that a history of TBI is associated with late-life cognitive decline and impairment in 
this relatively young older cohort, but there was no evidence for a role for APOE genotype in 
TBI related impairment in this age group (Millar et al., 2003). Decline in other cognitive 
domains, and in particular memory, may emerge as the cohort ages. The rate of decline 
observed in this study is relatively small, amounting to a fraction of a standard score per year. 
While this is of little clinical significance the pattern of interaction with genotype and sex is 
of interest for understanding outcomes in specific patient groups.   
 
In conclusion, our study supports previous findings that TBI predicts long-term cognitive 
decline in older adults. In addition we found TBI predicted cognitive decline in younger 
adults. Furthermore, APOE genotype and sex interacted with TBI history in predicting 
baseline cognitive impairment, and these interactions varied across the three age cohorts. 
Strengths of the present study include its prospective design, follow-up of over 6000 
community based individuals over a period of 8 years, and use of standard 
neuropsychological measures. Our study also included three age cohorts and multiple TBI 
variables to provide a thorough examination of TBI relationships with long-term cognitive 
performance. Significant limitations of the present study include the retrospective self-report 
of injuries, the non-standard categorization of mild and moderate/severe TBI, and the 
significantly lower number of reported TBIs in the older cohorts. Further, there was also 
limited information regarding the timing of TBI events relative to the cognitive assessments.  
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Table 1 TBI Variables  
 
TBI Variable Items and categorisation Wave* 
History of TBI  “Have you ever had a serious head injury that interfered 
with your memory, made you lose consciousness or caused 
a blood clot in your brain?” (Yes/No†) 
2,3 
Frequency  “How many head injuries have you had where you became 
unconscious for more than 15 minutes?” (continuous) 
1,2,3 
Severity  Mild: serious head injury with LOC <60 minutes or a 
period of memory loss up to 1 day†† 
Moderate/Severe: LOC  60 minutes and period of memory 
loss of more than 1 day†† 
2,3 
Age of first 
TBI 
“How old were you when you had the (first) head injury” 
(Categorised: Child(<18 years) /Adult(18 years)) 
1,2,3 
* Questions for wave 3 pertained to the period since the last interview at wave 2. 
† Those responding “uncertain” were excluded from analyses when using this variable. 
†† assumed to represent post-traumatic amnesia (PTA)  
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Table 2 Baseline characteristics of the study population according to age cohort 
  Age Cohort   
 20 40 60 p 
N 2077 2124 2132  
Age at baseline (years) 22.61(1.51) 42.62(1.49) 62.51(1.51)  
Female (%) 1108(53.3) 1145(53.9) 1056(49.5) <0.01 
BMI(kgm2) 23.57(4.1) 26.35(5.2) 26.86(5.30) <0.001 
Years of education 14.21(1.50) 14.43(2.28) 13.90(2.74) <0.001 
APOE genotype (%)    0.10 
3/ 3  1285(61.9) 1244(58.6) 1287(60.4)  
2/2 or 2/ 3 233(11.2) 294(13.8) 261(12.2)  
4+ 559(26.9) 586(27.6) 584(27.4)  
History of TBI (%)    <0.001 
Yes 207(10.0) 183(8.6) 99(4.6)  
No 1870(90.0) 1941(91.4) 2033(95.4)  
TBI severity (%)    <0.001 
Mild 176(8.5) 128(6.0) 66(3.1)  
Moderate/Severe 31 (1.5) 55(2.6) 33(1.5)  
Frequency of TBI (%)     
Single 107(5.2) 112(5.3) 69(3.2) <0.001 
Multiple 100(4.8) 71(3.3) 30(1.4)  
Age of first TBI (%)    <0.001 
Child (<18 years) 138(6.7) 89(4.2) 42(2.0)  
Adult ( >18 years) 57 (2.8) 88(4.2) 55(2.6)  
Cause of TBI (%)    <0.001 
Traffic accident 30(1.4) 68(3.2) 45(2.1)  
Sport 89(4.3) 59(2.8) 25(1.2)  
Assault 16(0.8) 8(0.4) 0(0.0)  
Fall 59(2.8) 30(1.4) 19(0.9)  
Other 13(0.6) 18(0.9) 10(0.5)  
Note. BMI = body mass index at baseline, TBI = traumatic brain injury 
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Table 3 TBI as a predictor of baseline and longitudinal cognitive function (B coefficients (standard errors)) 
 
TBI Variable in Mixed Model Interacting Variables§ Cognitive skill Age Cohort 
      (outcome variable) 20s 40s 60s 
Baseline Effects involving APOE 4+ 
History of TBI Yes  APOE 4+ Episodic Memory -5.40(1.79)** 
    
Severity of TBI Moderate/Severe  APOE 4+ Episodic Memory -5.89(1.84)** 
       
Age of first TBI First TBI as a child APOE 4+ Episodic Memory -5.90(2.14)** 
First TBI as a child APOE 4+ Reaction time -5.92(2.15)** 
 First TBI as an adult APOE 4+ Verbal Ability 2.82(1.29)*   
       
Frequency of TBI Multiple APOE 4+ Episodic Memory -7.32(2.51)** 
       
Baseline Effects involving sex 
Severity of TBI Moderate/Severe Male Episodic Memory   8.75(4.58)* 
 Mild Male Reaction Time   4.88(2.50)* 
       
Age of first TBI First TBI as a child Male Episodic Memory 6.72(3.21)* 
First TBI as an adult Male Verbal Ability -2.09(0.88)*   
    
Frequency of TBI Single Male Verbal Ability -1.45(0.72)*   
 Single Male Processing Speed  4.86(1.92)*  
       
Longitudinal Effects 
History of TBI Yes  Time Episodic Memory -0.39(0.13)** -0.27(0.13)* 
Yes Time Processing speed -0.26(0.10)* 
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Frequency of TBI Single Time Episodic Memory  -0.35(0.17)*  
Multiple Time Episodic Memory -0.53(0.20)* 
Single Time Processing speed -0.25(0.12)* 
       
Age of first TBI First TBI as a child Time Episodic Memory -0.37(0.16)* 
 First TBI as an adult Time Episodic Memory -0.43(0.20)* -0.40(0.17)*  
First TBI as an adult Time Processing speed -0.24(0.12)* 
        
§ Comparison group for all TBI terms is the No TBI group; comparison group for genotype is APOE 3/3, and for sex comparison is to Female.  
*p<0.05, ** p<0.01
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Figure Captions 
 
Figure 1. Flow chart of sample selection and follow-up.*Study sample excludes participants 
reporting baseline stroke or epilepsy. 
 
Figure 2. TBI as a predictor of baseline cognitive: interactions with APOE genotype.  
(A) TBI history and genotype as predictor of episodic memory in 20s cohort (B) TBI severity 
and APOE genotype as predictors of episodic memory in 20s cohort (C) Age of first TBI and 
APOE genotype as predictors of episodic memory in 20s (D) Age of first TBI and genotype 
as predictors of verbal ability in 20s cohort (E) TBI frequency and genotype as predictors of 
memory in 20s cohort (F) Age of first TBI and genotype as predictors of reaction time in 40s 
cohort. (Error bars represent +/-1 SEM)  
 
Figure 3. TBI as a predictor of baseline cognitive performance: interactions with sex.  
(A) Age of first TBI cause and sex as predictors of verbal ability in 20s cohort (B) TBI 
frequency and sex as predictors of verbal ability in 20s cohort (C) Age of first TBI and APOE 
genotype as predictors of memory in 40s cohort. (D) TBI frequency and sex as predictors of 
processing speed in 40s cohort. (E) TBI severity and sex as predictors of memory in 60s 
cohort. (F) TBI severity and sex as predictors of reaction time in 60s cohort (Error bars 
represent +/-1 SEM). 
 
 
 
 
